Profile data is unavailable for this security.
About the company
Quest Diagnostics Incorporated is a provider of diagnostic information services. The Company provides diagnostic insights from the results of its laboratory testing to enable people, physicians, and organizations to take action to improve health outcomes. It operates through the DIS segment, which provides diagnostic information services to a range of customers within its primary customer channels: physicians, hospitals, and patients and consumers. It offers broad access to clinical testing through a nationwide network of laboratories, patient service centers, phlebotomists in physician offices, and connectivity resources, including call centers and mobile phlebotomists, nurses and other health and wellness professionals. It also focuses on artificial intelligence (AI) and digital pathology solutions. The Company’s services primarily are provided under the Quest Diagnostics brand and under other brands, including AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum.
- Revenue in USD (TTM)10.16bn
- Net income in USD892.00m
- Incorporated1996
- Employees45.00k
- LocationQuest Diagnostics Inc500 Plaza DriveSECAUCUS 07094United StatesUSA
- Phone+1 (973) 520-2700
- Fax+1 (302) 655-5049
- Websitehttps://www.questdiagnostics.com/
More ▼
Mergers & acquisitions
| Acquired company | DGX:NYQ since announced | Transaction value |
|---|---|---|
| University Hospitals Health System-Outreach Laboratory Services Business | 10.60% | -- |
Data delayed at least 15 minutes, as of Jul 18 2025 21:00 BST.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Davita Inc | 12.97bn | 859.61m | 10.83bn | 76.00k | 14.19 | -- | 5.73 | 0.8347 | 10.10 | 10.10 | 152.64 | -3.46 | 0.7507 | 59.12 | 5.28 | 170,638.50 | 6.81 | 6.09 | 9.26 | 8.06 | 32.46 | 31.21 | 9.08 | 8.69 | 1.20 | 4.05 | 0.8544 | -- | 5.56 | 2.39 | 35.40 | 5.82 | -6.24 | -- |
| Universal Health Services Inc | 16.08bn | 1.20bn | 11.01bn | 86.00k | 9.59 | 1.62 | 6.08 | 0.6844 | 17.81 | 17.81 | 239.04 | 105.30 | 1.11 | -- | 6.83 | 187,024.10 | 8.43 | 6.68 | 10.01 | 7.94 | -- | -- | 7.58 | 6.62 | 1.23 | 9.84 | 0.4031 | 5.63 | 10.82 | 6.82 | 59.17 | 7.04 | 7.56 | 5.92 |
| Molina Healthcare Inc | 41.87bn | 1.18bn | 11.07bn | 18.00k | 9.87 | 2.56 | 8.11 | 0.2644 | 20.70 | 20.70 | 737.08 | 79.81 | 2.62 | -- | 12.24 | 2,325,889.00 | 7.37 | 7.30 | 15.44 | 15.96 | 15.22 | 15.66 | 2.81 | 2.86 | -- | 12.81 | 0.4663 | 0.00 | 19.31 | 19.29 | 8.07 | 9.85 | 11.90 | -- |
| Encompass Health Corp | 5.51bn | 494.00m | 11.14bn | 23.56k | 22.81 | 5.15 | 11.55 | 2.02 | 4.84 | 4.82 | 53.99 | 21.44 | 0.8565 | -- | 8.87 | 233,941.60 | 10.20 | 6.72 | 13.26 | 8.39 | 95.60 | 95.41 | 11.91 | 9.53 | -- | 7.09 | 0.457 | 26.04 | 11.91 | 3.13 | 26.02 | 4.94 | 9.72 | -10.27 |
| Hims & Hers Health Inc | 1.78bn | 164.40m | 11.19bn | 1.64k | 73.10 | 20.35 | 59.89 | 6.27 | 0.6839 | 0.6839 | 7.40 | 2.46 | 2.66 | 7.73 | 267.34 | 1,090,014.00 | 24.54 | -3.91 | 34.03 | -4.74 | 77.04 | -- | 9.21 | -2.35 | 1.32 | -- | 0.00 | -- | 69.33 | -- | 635.28 | 155.96 | -- | -- |
| Centene Corp | 169.28bn | 3.45bn | 14.50bn | 60.50k | 4.34 | 0.5193 | 3.09 | 0.0857 | 6.72 | 6.72 | 329.55 | 56.11 | 2.00 | -- | 8.62 | 2,798,083.00 | 4.07 | 2.79 | 6.93 | 4.42 | 10.27 | 11.27 | 2.04 | 1.48 | -- | 5.26 | 0.3954 | 0.00 | 5.89 | 16.92 | 22.32 | 20.13 | -2.48 | -- |
| Tenet Healthcare Corp | 20.52bn | 1.46bn | 16.27bn | 74.48k | 11.58 | 3.89 | 5.14 | 0.7928 | 15.12 | 15.12 | 212.60 | 45.01 | 0.7058 | 9.81 | 6.66 | 275,510.20 | 8.09 | 6.32 | 11.88 | 8.98 | 82.33 | 82.75 | 11.46 | 8.84 | 1.70 | 6.08 | 0.6035 | 0.00 | 0.5694 | 2.26 | 423.73 | -- | 6.80 | -- |
| Quest Diagnostics Inc | 10.16bn | 892.00m | 18.77bn | 45.00k | 21.39 | 2.72 | 13.07 | 1.85 | 7.86 | 7.86 | 89.50 | 61.87 | 0.6829 | 36.71 | 7.45 | 225,733.30 | 6.18 | 8.96 | 7.13 | 10.40 | 33.15 | 36.15 | 9.05 | 12.55 | 1.31 | 6.81 | 0.4541 | 25.68 | 6.70 | 5.02 | 1.88 | 0.7317 | 1.22 | 6.90 |
| Natera Inc | 1.83bn | -189.76m | 19.58bn | 4.42k | -- | 15.72 | -- | 10.69 | -1.47 | -1.47 | 14.28 | 9.12 | 1.14 | 14.98 | 6.03 | 413,878.80 | -11.86 | -30.60 | -15.01 | -38.82 | 61.79 | 51.43 | -10.36 | -40.61 | 3.74 | -- | 0.0609 | -- | 56.75 | 41.20 | 56.20 | -- | 72.97 | -- |
| Labcorp Holdings Inc | 13.18bn | 730.80m | 20.69bn | 70.00k | 28.51 | 2.49 | 13.12 | 1.57 | 8.67 | 8.67 | 156.36 | 99.13 | 0.7721 | 19.73 | 5.88 | 188,248.60 | 4.29 | 6.16 | 5.21 | 7.33 | 27.89 | 32.18 | 5.55 | 9.17 | 1.60 | 5.48 | 0.404 | -- | 6.97 | 2.40 | 96.73 | -1.96 | 4.13 | -- |
| Humana Inc | 120.26bn | 1.71bn | 26.98bn | 65.68k | 15.81 | 1.52 | 9.74 | 0.2244 | 14.14 | 14.14 | 996.52 | 147.08 | 2.38 | -- | -- | 1,831,029.00 | 3.62 | 6.19 | -- | -- | -- | -- | 1.52 | 2.69 | -- | 5.47 | 0.4275 | 15.11 | 10.70 | 12.66 | -51.51 | -14.92 | -4.82 | 10.49 |
Data as of Jul 18 2025. Currency figures normalised to Quest Diagnostics Inc's reporting currency: US Dollar USD
42.06%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 31 Mar 2025 | 13.40m | 12.07% |
| BlackRock Fund Advisorsas of 31 Mar 2025 | 6.37m | 5.74% |
| T. Rowe Price Associates, Inc. (IM)as of 31 Mar 2025 | 5.82m | 5.24% |
| SSgA Funds Management, Inc.as of 31 Mar 2025 | 5.18m | 4.67% |
| JPMorgan Investment Management, Inc.as of 31 Mar 2025 | 3.31m | 2.99% |
| Victory Capital Management, Inc. (Investment Management)as of 31 Mar 2025 | 3.13m | 2.82% |
| Geode Capital Management LLCas of 31 Mar 2025 | 2.77m | 2.50% |
| Davis Selected Advisers LPas of 31 Mar 2025 | 2.39m | 2.15% |
| Boston Partners Global Investors, Inc.as of 31 Mar 2025 | 2.30m | 2.07% |
| Grantham, Mayo, Van Otterloo & Co. LLCas of 31 Mar 2025 | 2.01m | 1.81% |
More ▼
Data from 31 Mar 2025 - 31 Mar 2025Source: FactSet Research Systems Inc.
